We were unable to determine a relationship between the alterations in EGFR, HER2, TOP2A, chromosome 7, or chromosome 17 and the clinicopathologic characteristics of gastric carcinoma; this is in contrast to previous reports, and may be due to different sample numbers and different populations. This evidence concerns the gene EGFR and gastric carcinoma.